Immunomodulator
Nearly one-third of rheumatology drug regimens shifted at time of COVID-19 vaccination
As many as 27.9% of immunomodulatory or immunosuppressive regimens were changed around the time of COVID-19 vaccination, with patients responsible for most modifications, according to data published in The Lancet Rheumatology.
Immunomodulators an option for prepping patients with dry eye before cataract surgery
WAILEA, Hawaii — Lifitegrast and cyclosporine are not only useful for long-term management of dry eye disease but are also effective in pre-cataract surgery patients with dry eye, according to a speaker at Hawaiian Eye 2021.
Bortezomib-based intensification treatment improves PFS after induction therapy in multiple myeloma
Response-adapted intensification treatment with a bortezomib-based regimen improved PFS among patients with newly diagnosed multiple myeloma who achieved minimal or partial response to immunomodulatory induction therapy, according to results of a randomized phase 3 study published in The Lancet Haematology.
Not dead yet: The role of immunomodulators in IBD
ORLANDO — Thiopurine immunomodulators represent a potentially inexpensive and effective method for inflammatory bowel disease maintenance that can be underused as biologics became available, according to a keynote presentation from Advances in Inflammatory Bowel Disease 2019.